Sleep Apnea Pill Cuts Breathing Pauses 44% in Major Trial

A new nightly pill reduced sleep apnea episodes by 44% in clinical trials, offering hope to nearly 1 billion people worldwide who struggle with the condition.

The FDA has fast-tracked approval, with a decision expected in 2027.